Biofrontera AG (BFRA) Social Stream
Biofrontera AG (BFRA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BFRA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-18 | 1 | $8 | $8 | $8 | $2.67 | 199.63% |
Price Target Last Issued June 18, 2021
The Trend in the Analyst Price Target
BFRA's average price target has moved down $4.57 over the prior 36 weeks.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-06-18 | 1 | 8 | 8 | 8 | 6.53 | 22.51% |
BFRA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Biofrontera AG's number of analysts covering the stock is higher than just about none of of them.
- BFRA has a lower variance in analysts' estimates than almost 100% of all US stocks.
- BFRA has a higher average analyst price target than 11.6% of Healthcare stocks.
- In the context of stocks in the small market cap category, Biofrontera AG's upside potential (average analyst target price relative to current price) is greater than 68.26% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Biofrontera AG are BDSI, BCYC, and BCEL.
What is the outlook for BFRA? Use POWR Ratings for clearer insight into price direction.